Laddar...
Thymidylate synthase predicts poor response to pemetrexed chemotherapy in patients with advanced breast cancer
Pemetrexed is a candidate chemotherapy regimen for anthracycline- and taxane-pretreated advanced breast cancer. However, to the best of our knowledge, no efficient treatment efficacy biomarkers have been identified. In the present study, the potential correlation between thymidylate synthase (TYMS)...
Sparad:
| I publikationen: | Oncol Lett |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
D.A. Spandidos
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6096094/ https://ncbi.nlm.nih.gov/pubmed/30127925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8973 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|